GO
Loading...

Ireland

More

  • Ailing Malaysia Airlines readies for drastic overhaul Wednesday, 4 Mar 2015 | 3:49 AM ET

    KUALA LUMPUR, Malaysia— After a year of calamity, Malaysia Airlines is shrinking to survive. His new bosses hope he'll be able to pull off a similar feat at Malaysia Airlines though analysts say success is far from guaranteed because of the political baggage of being a state-owned company. At least four other major restructurings of Malaysia Airlines since 2001...

  • Why Ireland needs retirement reforms: CEO  Wednesday, 4 Mar 2015 | 2:50 AM ET

    Speaking to CNBC, Bill Kyle, CEO of Irish Life Group, said Ireland needs to look at retirement reform.

  • New Malaysia Airlines CEO a "battle hardened" veteran Wednesday, 4 Mar 2015 | 2:48 AM ET

    HONG KONG— When the owners of embattled Malaysia Airlines went looking for a new CEO to lead its restructuring, they chose a German turnaround specialist known as "The Terminator" to take on what's been dubbed the toughest job in aviation. Christoph Mueller, 52, comes to the post fresh from a stint reviving Ireland's Aer Lingus. "The first year of a restructuring is...

  • Strong growth ahead for Ireland: CEO  Wednesday, 4 Mar 2015 | 1:20 AM ET

    Danny McCoy, CEO of IBEC, tells CNBC that despite high debt levels in Ireland, he sees a strong year of growth ahead.

  • Ireland must support SMEs: CEO  Wednesday, 4 Mar 2015 | 1:20 AM ET

    Gary McGann, CEO of Smurfit Kappa, tells CNBC that Ireland needs to support SMEs which are fundamental to a sustainable recovery.

  • FACTBOX-How Europe's "bad banks" have fared Monday, 2 Mar 2015 | 12:12 PM ET

    Belgium had two major banking failures, Fortis and Dexia. With the former, toxic assets were purchased for 11.7 billion euros by a separate vehicle Royal Park Investments, owned by Fortis, the Belgian state and BNP Paribas. Credit Suisse and Lone Star Funds bought RPI's assets for 6.7 billion euros in 2013. RPI is active now only in U.S. legal disputes.

  • DUBLIN/ MADRID, March 2- Europe's tough treatment of Greece's new government has eased some immediate anti-austerity pressure in Ireland and Spain, but it may take a lot more than that to put Dublin and Madrid's ruling parties' re-election prospects back on track. They both toed the line with Germany in demanding that Greece stick to its bailout commitments- a...

  • Endo reports 4Q loss Monday, 2 Mar 2015 | 7:21 AM ET

    DUBLIN 4, Ireland _ Endo International PLC on Monday reported a loss of $53.5 million in its fourth quarter. The Dublin 4, Ireland- based company said it had a loss of 35 cents per share. The average estimate of analysts surveyed by Zacks Investment Research was for earnings of $1.13 per share.

  • Dublin- based Actavis Plc holds the commercial license for the product, but the marketing application was submitted by non-profit pharmaceutical company Medicines360, which holds the U.S. public sector clinic rights. The companies expect the device, which also helps to check heavy menstrual bleeding, to be available in the United States by the second quarter...

  • Horizon Pharma reports 4Q loss Friday, 27 Feb 2015 | 7:21 AM ET

    DUBLIN _ Horizon Pharma Inc. on Friday reported a loss of $31.6 million in its fourth quarter. The Dublin- based company said it had a loss of 27 cents per share. For the year, the company reported that its loss widened to $263.6 million, or $3.15 per share.

  • Global Indemnity posts 4Q profit Friday, 27 Feb 2015 | 5:13 AM ET

    DUBLIN _ Global Indemnity PLC on Thursday reported fourth-quarter profit of $11.1 million. The Dublin- based company said it had profit of 44 cents per share. Keywords: Global Indemnity, Earnings Report.

  • DUBLIN, Feb 26- Malin, an Irish company set up by a number of former Elan executives to invest in privately held life science assets, said it plans to raise between 275 million and 325 million euros in one of Europe's biggest biotechnology IPOs. Former Elan chief executive Kelly Martin and chairman Bob Ingram, who sold the Irish stock market stalwart to Perrigo for...

  • Cramer Remix: This stock, and llamas, on the run Thursday, 26 Feb 2015 | 7:06 PM ET

    Llamas weren’t the only things running wild on Thursday; “Mad Money” host Jim Cramer has a stock galloping higher.

  • Cramer: 'I'm a happy camper'—Thanks, Europe! Thursday, 26 Feb 2015 | 6:22 PM ET
    Mario Draghi, president of the European Central Bank (ECB), looks on as he unveils a new twenty-euro banknote at the ECB headquarters in Frankfurt, Germany, Feb. 24, 2015.

    Jim Cramer wants to be negative about what's happening in the market right now but with this evidence, he can't!

  • Feb 26- Google Inc has combined its two European regional divisions as it seeks to meet the challenges of tougher regulation across the continent, a source close to the company said on Thursday. In response, Google has argued that for Europe to remain competitive in global markets, it needs to form a single digital market instead of relying on national...

  • FDA approves new antibiotic combo from Actavis Wednesday, 25 Feb 2015 | 6:02 PM ET

    The drug from Actavis PLC contains two ingredients, cephalosporin and avibactam, designed to help fight antibiotic-resistant bacteria. The Food and Drug Administration approved Avycaz to treat certain abdominal infections, in combination with another drug, and for complicated urinary-tract infections, including kidney infections, for which there are...

  • LONDON, Feb 25- Ireland has no problem in principle with the idea of swapping Greece's official debt for growth-linked bonds but would have to see the details of any proposal, Finance Minister Michael Noonan said on Wednesday. Euro zone finance ministers agreed on Tuesday to a four-month extension of Greece's EU/IMF bailout programme, subject to its economic...

  • Jazz tops Street 4Q forecasts Tuesday, 24 Feb 2015 | 7:09 PM ET

    DUBLIN _ Jazz Pharmaceuticals PLC on Tuesday reported fourth-quarter net income of $81.6 million. The average estimate of analysts surveyed by Zacks Investment Research was for earnings of $2.34 per share. Analysts expected $321 million, according to Zacks.

  • Alkermes beats Street 4Q forecasts Tuesday, 24 Feb 2015 | 11:58 AM ET

    DUBLIN _ Alkermes PLC on Tuesday reported fourth-quarter earnings of $30.5 million. The average estimate of analysts surveyed by Zacks Investment Research was for earnings of 4 cents per share. Alkermes shares have increased 26 percent since the beginning of the year.

  • Feb 24- Facebook Inc said on Tuesday that its active advertisers rose to 2 million, a 33 percent increase from the 1.5 million it had in July 2014. Facebook does not break out the actual number of small business advertisers versus big brands, but they tend to spend on average $5 to $50 a day. Sandberg said that the fastest areas of growth of small business advertising...